ID

29550

Description

Study ID: 102932 Clinical Study ID: HZA102932 Study Title:An open-label, randomised, 3-way crossover single dose study to demonstrate dose proportionality of fluticasone furoate (FF) and equivalence of vilanterol (VI) when administered as FF/VI inhalation powder from the novel dry powder inhaler in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01213849 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: Allermist,Veramyst,Avamys; Veramyst,Avamys,Allermist Study Indication: Asthma Documentation part: LOGS and Repeats

Mots-clés

Versions (2)
  1. 10/03/2018 10/03/2018 -
  2. 05/04/2018 05/04/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

5 avril 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Dose proportionality of fluticasone furoate and equivalence of vilanterol in healthy adults NCT01213849

Anglais

LOGS and Repeats

1 Formulaires  
  1. StudyEvent: ODM
    1. LOGS and Repeats
ADVERSE EVENT/CONCOMITANT MEDICATION/REPEAT ASSESSMENT CHECK QUESTIONS
Description

ADVERSE EVENT/CONCOMITANT MEDICATION/REPEAT ASSESSMENT CHECK QUESTIONS

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0877248
UMLS CUI-3
C0008976
UMLS CUI-4
C1320722
Date of visit/assessment
Description

Date of visit/assessment

Type de données

date

Alias
UMLS CUI [1]
C1320303
Were any concomitant medications taken by the subject during the study?
Description

concomitant medications

Type de données

boolean

Alias
UMLS CUI [1]
C2347852
Did the subject experience any non-serious adverse events during the study?
Description

non-serious adverse events

Type de données

boolean

Alias
UMLS CUI [1]
C1518404
Did the subject experience any serious adverse events during the study?
Description

serious adverse events

Type de données

boolean

Alias
UMLS CUI [1]
C1519255
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
Description

abnormal ECG

Type de données

boolean

Alias
UMLS CUI [1]
C0522055
Were any repeat haematology or clinical chemistry samples taken?
Description

repeat haematology or clinical chemistry samples taken

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0018941
UMLS CUI [1,3]
C0200345
Were any repeat urinalysis samples taken?
Description

urinalysis samples

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042014
UMLS CUI [1,2]
C0200345
Were any repeat ECGs performed?
Description

ECG

Type de données

boolean

Alias
UMLS CUI [1]
C0013798
Were any repeat vital signs recorded?
Description

vital signs

Type de données

boolean

Alias
UMLS CUI [1]
C0518766
Were any repeat Pulmonary Function Tests performed?
Description

Pulmonary Function Tests

Type de données

boolean

Alias
UMLS CUI [1]
C0024119
Were any repeat PK blood samples taken?
Description

PK blood samples taken

Type de données

boolean

Alias
UMLS CUI [1,1]
C1277698
UMLS CUI [1,2]
C0031327
Any IP device malfunctions?
Description

IP device malfunctions

Type de données

boolean

Alias
UMLS CUI [1]
C0699733
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
Description

liver chemistry

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0008000
UMLS CUI [1,3]
C0587081
Retour au début de la page

Similar models

LOGS and Repeats

1 Formulaires
  1. StudyEvent: ODM
    1. LOGS and Repeats
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ADVERSE EVENT/CONCOMITANT MEDICATION/REPEAT ASSESSMENT CHECK QUESTIONS
C2347852 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
C1320722 (UMLS CUI-4)
Date of visit/assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
concomitant medications
Item
Were any concomitant medications taken by the subject during the study?
boolean
C2347852 (UMLS CUI [1])
non-serious adverse events
Item
Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
serious adverse events
Item
Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
abnormal ECG
Item
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
boolean
C0522055 (UMLS CUI [1])
repeat haematology or clinical chemistry samples taken
Item
Were any repeat haematology or clinical chemistry samples taken?
boolean
C0008000 (UMLS CUI [1,1])
C0018941 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
urinalysis samples
Item
Were any repeat urinalysis samples taken?
boolean
C0042014 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
ECG
Item
Were any repeat ECGs performed?
boolean
C0013798 (UMLS CUI [1])
vital signs
Item
Were any repeat vital signs recorded?
boolean
C0518766 (UMLS CUI [1])
Pulmonary Function Tests
Item
Were any repeat Pulmonary Function Tests performed?
boolean
C0024119 (UMLS CUI [1])
PK blood samples taken
Item
Were any repeat PK blood samples taken?
boolean
C1277698 (UMLS CUI [1,1])
C0031327 (UMLS CUI [1,2])
IP device malfunctions
Item
Any IP device malfunctions?
boolean
C0699733 (UMLS CUI [1])
liver chemistry
Item
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
boolean
C0232741 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial